{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "S-ACE2", "main protease", "molecular dynamics simulation", "natural medicinal plants", "structure-based virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34291081", "DateRevised": {"Year": "2021", "Month": "07", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "05"}], "Language": ["eng"], "ELocationID": ["637122", "10.3389/fmolb.2021.637122"], "Journal": {"ISSN": "2296-889X", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in molecular biosciences", "ISOAbbreviation": "Front Mol Biosci"}, "ArticleTitle": "<i>In silico</i> Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19.", "Pagination": {"StartPage": "637122", "MedlinePgn": "637122"}, "Abstract": {"AbstractText": ["COVID-19 is one of the members of the coronavirus family that can easily assail humans. As of now, 10 million people are infected and above two million people have died from COVID-19 globally. Over the past year, several researchers have made essential advances in discovering potential drugs. Up to now, no efficient drugs are available on the market. The present study aims to identify the potent phytocompounds from different medicinal plants (<i>Zingiber officinale</i>, <i>Cuminum cyminum</i>, <i>Piper nigrum</i>, <i>Curcuma longa</i>, and <i>Allium sativum</i>). In total, 227 phytocompounds were identified and screened against the proteins S-ACE2 and M <sup><i>pro</i></sup> through structure-based virtual screening approaches. Based on the binding affinity score, 30 active phytocompounds were selected. Amongst, the binding affinity for beta-sitosterol and beta-elemene against S-ACE2 showed -12.0 and -10.9 kcal/mol, respectively. Meanwhile, the binding affinity for beta-sitosterol and beta-chlorogenin against M <sup><i>pro</i></sup> was found to be -9.7 and -8.4 kcal/mol, respectively. Further, the selected compounds proceeded with molecular dynamics simulation, prime MM-GBSA analysis, and ADME/T property checks to understand the stability, interaction, conformational changes, binding free energy, and pharmaceutical relevant parameters. Moreover, the hotspot residues such as Lys31 and Lys353 for S-ACE2 and catalytic dyad His41 and Cys145 for M <sup><i>pro</i></sup> were actively involved in the inhibition of viral entry. From the in silico analyses, we anticipate that this work could be valuable to ongoing novel drug discovery with potential treatment for COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 Sankar, Ramachandran, Pandi, Mutharasappan, Ramasamy, Prabu, Shanmugaraj, Wang, Muniyandai, Rathinasamy, Chandrasekaran, Bayan, Jeyaraman, Halliah and Ebenezer."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Sankar", "ForeName": "Muthumanickam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Ramachandran", "ForeName": "Balajee", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Pandi", "ForeName": "Boomi", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Mutharasappan", "ForeName": "Nachiappan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Ramasamy", "ForeName": "Vidhyavathi", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kumaraguru College of Technology, Coimbatore, India."}], "LastName": "Prabu", "ForeName": "Poorani Gurumallesh", "Initials": "PG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Alagappa University, Karaikudi, India."}], "LastName": "Shanmugaraj", "ForeName": "Gowrishankar", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, School of Life Science, Anyang Institute of Technology, Anyang, China."}], "LastName": "Wang", "ForeName": "Yao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Health and Management, Science Campus, Alagappa University, Karaikudi, India."}], "LastName": "Muniyandai", "ForeName": "Brintha", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sri Ramakrishna College of Arts and Science, Bharathiar University, Coimbatore, India."}], "LastName": "Rathinasamy", "ForeName": "Subaskumar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Philadelphia University-Jordan, Philadelphia University, Jordan."}], "LastName": "Chandrasekaran", "ForeName": "Balakumar", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Philadelphia University-Jordan, Philadelphia University, Jordan."}], "LastName": "Bayan", "ForeName": "Mohammad F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Alagappa University, Karaikudi, India."}], "LastName": "Jeyaraman", "ForeName": "Jeyakanthan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Industrial Chemistry, School of Chemical Sciences, Alagappa University, Karaikudi, India."}], "LastName": "Halliah", "ForeName": "Gurumallesh Prabu", "Initials": "GP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioscience Research Foundation, Chennai, India."}], "LastName": "Ebenezer", "ForeName": "Solomon King", "Initials": "SK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Mol Biosci", "NlmUniqueID": "101653173", "ISSNLinking": "2296-889X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adejoro I. S., Babatunde D. D., Tolufashe G. T. (2020). Molecular docking and dynamic simulations of some medicinal plants compounds againstSARS-CoV-2: an in silico study. Taibah Univ. Sci. 14 1563\u20131570. 10.1080/16583655.2020.1848049", "ArticleIdList": ["10.1080/16583655.2020.1848049"]}, {"Citation": "Alexpandi R., De Mesquita J. F., Pandian S. K., Ravi A. V. (2020). Quinolines-based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: an in silico analysis. Front. Microbiol. 11:1796.", "ArticleIdList": ["PMC7390959", "32793181"]}, {"Citation": "Arul Murugan N., Chitra J. P., Jeyakanthan J. (2020). Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against sars-cov-2 in comparison to known antiviral compounds in drug trials. J. Biomol. Struct. Dyn. 16 1\u201312. 10.1080/07391102.2020.1777901", "ArticleIdList": ["10.1080/07391102.2020.1777901", "PMC7309306", "32543978"]}, {"Citation": "Babich O., Sukhikh S., Prosekov A., Asyakina L., Ivanova S. (2020). Medicinal Plants to Strengthen Immunity during a Pandemic. Pharmaceuticals 13:313. 10.3390/ph13100313", "ArticleIdList": ["10.3390/ph13100313", "PMC7602650", "33076514"]}, {"Citation": "Bai C., Warshel A. (2020). Critical differences between the binding features of the spike proteins of SARS-CoV-2 and SARS-CoV. J. Phys. Chem. B 124 5907\u20135912. 10.1021/acs.jpcb.0c04317", "ArticleIdList": ["10.1021/acs.jpcb.0c04317", "PMC7341686", "32551652"]}, {"Citation": "Baig A. M., Khaleeq A., Syeda H. (2020). Docking prediction of amantadine in the receptor binding domain of spike protein of SARS-CoV-2. ACS Pharmacol. Transl. Sci 3 1430\u20131433. 10.1021/acsptsci.0c00172", "ArticleIdList": ["10.1021/acsptsci.0c00172", "PMC7737314", "33344913"]}, {"Citation": "Battisti V., Wieder O., Garon A., Seidel T., Urban E., Langer T. (2020). A computational approach to identify potential novel inhibitors against the coronavirus SARS-CoV-2. Mol. Inform. 39:2000090. 10.1002/minf.202000090", "ArticleIdList": ["10.1002/minf.202000090", "PMC7583376", "32721082"]}, {"Citation": "Benarba B., Pandiella A. (2020). Medicinal plants as sources of active molecules against COVID-19. Front. Pharmacol. 11:1189.", "ArticleIdList": ["PMC7427466", "32848790"]}, {"Citation": "Ben-Shabat S., Yarmolinsky L., Porat D., Dahan A. (2020). Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies. Drug Deliv. Transl. Res. 10 354\u2013367. 10.1007/s13346-019-00691-6", "ArticleIdList": ["10.1007/s13346-019-00691-6", "PMC7097340", "31788762"]}, {"Citation": "Bharadwaj S., Lee K. E., Dwivedi V. D., Kang S. G. (2020). Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations. Life Sciences. 257 118080. 10.1016/j.lfs.2020.118080", "ArticleIdList": ["10.1016/j.lfs.2020.118080", "PMC7347340", "32653520"]}, {"Citation": "Cavasotto C., Di Filippo J. (2020). In silico drug repurposing for COVID-19: targeting SARS-CoV-2 proteins through docking and consensus ranking. Mol. Inform. 40:2000115. 10.1002/minf.202000115", "ArticleIdList": ["10.1002/minf.202000115", "32722864"]}, {"Citation": "Cavasotto C. N., Lamas S. M., Maggini J. (2021). Functional and druggability analysis of the SARS-CoV-2 proteome. Eur. J. Pharmacol. 890:173705. 10.1016/j.ejphar.2020.173705", "ArticleIdList": ["10.1016/j.ejphar.2020.173705", "PMC7604074", "33137330"]}, {"Citation": "Chandra Babu T. M., Rajesh S. S., Bhaskar B. V., Devi S., Rammohan A., Sivaraman T., et al. (2017). Molecular docking, molecular dynamics simulation, biological evaluation and 2D QSAR analysis of flavonoids from Syzygium alternifolium as potent anti-Helicobacter pylori agents. RSC Adv. 7 18277\u201318292. 10.1039/c6ra27872h", "ArticleIdList": ["10.1039/c6ra27872h"]}, {"Citation": "Cheng V. C., Wong S. C., Chuang V. W., So S. Y., Chen J. H., Sridhar S., et al. (2020). The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J. Infect. 81 107\u2013114. 10.1016/j.jinf.2020.04.024", "ArticleIdList": ["10.1016/j.jinf.2020.04.024", "PMC7177146", "32335167"]}, {"Citation": "Chikhale R. V., Gurav S. S., Patil R. B., Sinha S. K., Prasad S. K., Shakya A., et al. (2020). Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J. Biomol. Struct. Dyn. 2020 1\u201312. 10.1080/07391102.2020.1778539", "ArticleIdList": ["10.1080/07391102.2020.1778539", "PMC7332873", "32568012"]}, {"Citation": "Chirumbolo S. (2012). Plant phytochemicals as new potential drugs for immune disorders and cancer therapy: really a promising path? J. Sci. Food Agric. 92 1573\u20131577. 10.1002/jsfa.5670", "ArticleIdList": ["10.1002/jsfa.5670", "22473298"]}, {"Citation": "Choudhary S., Malik Y. S., Tomar S. (2020). Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach. Front. Immunol. 11:1664. 10.3389/fimmu.2020.01664", "ArticleIdList": ["10.3389/fimmu.2020.01664", "PMC7365927", "32754161"]}, {"Citation": "Chowdhury P. (2019). In silico investigation of phytoconstituents from Indian medicinal herb \u2018Tinospora cordifolia (giloy)\u2019 against SARS-CoV-2 (COVID-19) by molecular dynamics approach. J. Biomol. Struct. Dyn. 7 1\u201318. 10.1080/07391102.2020.1803968", "ArticleIdList": ["10.1080/07391102.2020.1803968", "PMC7484574", "32762511"]}, {"Citation": "Ferraz W. R., Gomes R. A., Novaes A. L. S., Goulart Trossini G. H. (2020). Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study. Future Med. Chem. 20 1815\u20131828. 10.4155/fmc-2020-0165", "ArticleIdList": ["10.4155/fmc-2020-0165", "PMC7453759", "32787684"]}, {"Citation": "Gao J., Zhang L., Liu X., Li F., Ma R., Zhu Z., et al. (2020). Repurposing low\u2013molecular-weight drugs against the main protease of severe acute respiratory syndrome coronavirus 2. J. Phys. Chem. Lett 11 7267\u20137272. 10.1021/acs.jpclett.0c01894", "ArticleIdList": ["10.1021/acs.jpclett.0c01894", "32787337"]}, {"Citation": "Gowrishankar S., Muthumanickam S., Kamaladevi A., Karthika C., Jothi R., Boomi P., et al. (2021). Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 \u2013 an in silico study. Food Chem. Toxicol. 148:111966. 10.1016/j.fct.2020.111966", "ArticleIdList": ["10.1016/j.fct.2020.111966", "PMC7780060", "33412235"]}, {"Citation": "Guo R., Zhang Y., Li X., Song X., Li D., Zhao Y. (2016). Discovery of ERBB3 inhibitors for non-small cell lung cancer (NSCLC) via virtual screening. J. Mol. Model 22:135. 10.1007/s00894-016-3007-z", "ArticleIdList": ["10.1007/s00894-016-3007-z", "27188722"]}, {"Citation": "Halder T., Dhorajiwala T. M., Samant L. R. (2019). Multiple docking analysis and In silico absorption, distribution, metabolism, excretion, and toxicity screening of anti-leprosy phytochemicals and dapsone against dihydropteroate synthase of Mycobacterium leprae. Int. J. Mycobacteriol. 8 229\u2013236. 10.4103/ijmy.ijmy_123_19", "ArticleIdList": ["10.4103/ijmy.ijmy_123_19", "31512598"]}, {"Citation": "Huynh T., Wang H., Luan B. (2020). In silico exploration of the molecular mechanism of clinically, oriented drugs for possibly inhibiting SARS-CoV-2\u2032s main protease. J. Phys. Chem. Lett. 11 4413\u20134420. 10.1021/acs.jpclett.0c00994", "ArticleIdList": ["10.1021/acs.jpclett.0c00994", "32406687"]}, {"Citation": "Khanna K., Kohli S. K., Kaur R., Bhardwaj A., Bhardwaj V., Ohri P., et al. (2020). Herbal immune-boosters: substantial warriors of pandemic Covid-19 battle. Phytomedicine 85:153361. 10.1016/j.phymed.2020.153361", "ArticleIdList": ["10.1016/j.phymed.2020.153361", "PMC7532351", "33485605"]}, {"Citation": "Linh Nguyen H., Quoc Thai N., Toan Truong D., Suan Li M. (2020). Remdesivir strongly binds to both RNA-Dependent RNA polymerase and main protease of SARS-CoV-2: evidence from molecular simulations. J. Phys. Chem. B 124 11337\u201311348. 10.1021/acs.jpcb.0c07312", "ArticleIdList": ["10.1021/acs.jpcb.0c07312", "PMC7724981", "33264025"]}, {"Citation": "Meyer-Almes F.-J. (2020). Repurposing approved drugs as potential Inhibitors of 3CL-protease of SARS-CoV-2: virtual screening and structure based drug design. Comput. Biol. Chem. 88:107351. 10.1016/j.compbiolchem.2020.107351", "ArticleIdList": ["10.1016/j.compbiolchem.2020.107351", "PMC7832737", "32769050"]}, {"Citation": "Mukhtar M., Arshad M., Ahmad M., Pomerantz R. J., Wigdahl B., Parveen Z. (2008). Antiviral potentials of medicinal plants. Virus Res. 131 111\u2013120. 10.1016/j.virusres.2007.09.008", "ArticleIdList": ["10.1016/j.virusres.2007.09.008", "PMC7114233", "17981353"]}, {"Citation": "Muthumanickam S., Indhumathi T., Boomi P., Balajee R., Jeyakanthan J., Anand K., et al. (2020). In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer. J. Biomol. Struct. Dyn. 9 1\u201310. 10.1080/07391102.2020.1830855", "ArticleIdList": ["10.1080/07391102.2020.1830855", "33034258"]}, {"Citation": "Parvez M. K., Rehman M. T., Alam P., Al-Dosari M. S., Alqasoumi S. I, Alajmi M. F. (2019). Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: cell culture and molecular docking study. Saudi Pharm. J. 27:389. 10.1016/j.jsps.2018.12.008", "ArticleIdList": ["10.1016/j.jsps.2018.12.008", "PMC6439212", "30976183"]}, {"Citation": "Qi F., Qian S., Zhang S., Zhang Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 526 135\u2013140. 10.1016/j.bbrc.2020.03.044", "ArticleIdList": ["10.1016/j.bbrc.2020.03.044", "PMC7156119", "32199615"]}, {"Citation": "Rajagopal K., Byran G., Jupudi S., Vadivelan R. (2020). Activity of phytochemical constituents of black pepper, ginger, and garlic against coronavirus (COVID-19): an in silico approach. Int. J. Health Allied Sci. 9 43\u201350."}, {"Citation": "Ramachandran B., Srinivasadesikan V., Chou T.-M., Jeyakanthan J., Lee S.-L. (2020). Atomistic simulation on flavonoids derivatives as potential inhibitors of bacterial gyrase of Staphylococcus aureus. J. Biomol. Struct. Dyn. 1\u201314. 10.1080/07391102.2020.1856184", "ArticleIdList": ["10.1080/07391102.2020.1856184", "33308046"]}, {"Citation": "Rowaiye A. B., Onuh O. A., Sunday R. M., Abdulmalik Z. D., Bur D., Emeter N. W., et al. (2020). Structure-based virtual screening and molecular dynamic simulation studies of the natural inhibitors of SARS-CoV-2 main protease. J. Chem. Res. 5 20\u201331."}, {"Citation": "Schoeman D., Fielding B. C. (2019). Coronavirus envelope protein: current knowledge. Virol. J. 16:69.", "ArticleIdList": ["PMC6537279", "31133031"]}, {"Citation": "Selvaraj C., Singh S. K. (2014). Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation. J. Biomol. Struct. Dyn. 32 1333\u20131349. 10.1080/07391102.2013.818577", "ArticleIdList": ["10.1080/07391102.2013.818577", "23869520"]}, {"Citation": "Shyr Z. A., Gorshkov K., Chen C. Z., Zheng W. (2020). Drug discovery strategies for SARS-CoV-2. J. Pharmacol. Exp. Ther. 375 127\u2013138. 10.1124/jpet.120.000123", "ArticleIdList": ["10.1124/jpet.120.000123", "PMC7569306", "32723801"]}, {"Citation": "Tanaka T., Ikeda T., Kaku M., Zhu X. H., Okawa M., Yokomizo K., et al. (2004). New lignan glycoside and phenylethanoid glycosides from Strobilanthes cusia BREMEK. Chem. Pharm. Bull. 52 1242\u20131245. 10.1248/cpb.52.1242", "ArticleIdList": ["10.1248/cpb.52.1242", "15467245"]}, {"Citation": "Tariq A., Mateen R. M., Afzal M. S., Saleem M. (2020). Paromomycin: a potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19. Int. J. Infect. Dis. 98 166\u2013175. 10.1016/j.ijid.2020.06.063", "ArticleIdList": ["10.1016/j.ijid.2020.06.063", "PMC7306207", "32579907"]}, {"Citation": "Touret F., Gilles M., Barral K., Nougair\u00e8de A., van Helden J., Decroly E., et al. (2020). In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci. Rep. 10: 70143.", "ArticleIdList": ["PMC7403393", "32753646"]}, {"Citation": "Walls A. C., Park Y.-J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181 281\u2013292.e6.", "ArticleIdList": ["PMC7102599", "32155444"]}, {"Citation": "Wang J. (2020). Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. J. Chem. Inf. Model 60 3277\u20133286. 10.1021/acs.jcim.0c00179", "ArticleIdList": ["10.1021/acs.jcim.0c00179", "PMC7197972", "32315171"]}, {"Citation": "Whisenant J., Burgess K. (2019). Blocking Coronavirus 19 Infection via the SARS-CoV-2 spike protein: initial steps. ACS Med. Chem. Lett. 2020 1076\u20131078. 10.1021/acsmedchemlett.0c00233", "ArticleIdList": ["10.1021/acsmedchemlett.0c00233", "PMC7241730", "32547694"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "2"}, {"Year": "2021", "Month": "4", "Day": "16"}, {"Year": "2021", "Month": "7", "Day": "22", "Hour": "6", "Minute": "36"}, {"Year": "2021", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "7", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["34291081", "PMC8288047", "10.3389/fmolb.2021.637122"]}}], "PubmedBookArticle": []}